180 related articles for article (PubMed ID: 35984322)
1. Dry powder inhalation, part 2: the present and future.
de Boer AH; Hagedoorn P; Grasmeijer F
Expert Opin Drug Deliv; 2022 Sep; 19(9):1045-1059. PubMed ID: 35984322
[TBL] [Abstract][Full Text] [Related]
2. Dry powder inhalation: past, present and future.
de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW
Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768
[TBL] [Abstract][Full Text] [Related]
3. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
Komase Y; Asako A; Kobayashi A; Sharma R
Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
Moore A; Riddell K; Joshi S; Chan R; Mehta R
J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
[TBL] [Abstract][Full Text] [Related]
5. InVitro Evaluation of Optimal Inhalation Flow Patterns for Commercial Dry Powder Inhalers and Pressurized Metered Dose Inhalers With Human Inhalation Flow Pattern Simulator.
Hira D; Okuda T; Mizutani A; Tomida N; Okamoto H
J Pharm Sci; 2018 Jun; 107(6):1731-1735. PubMed ID: 29428382
[TBL] [Abstract][Full Text] [Related]
6. The clinical relevance of dry powder inhaler performance for drug delivery.
Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
[TBL] [Abstract][Full Text] [Related]
7. Applications of capsule dosing techniques for use in dry powder inhalers.
Edwards D
Ther Deliv; 2010 Jul; 1(1):195-201. PubMed ID: 22816126
[TBL] [Abstract][Full Text] [Related]
8. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers.
Capanoglu M; Dibek Misirlioglu E; Toyran M; Civelek E; Kocabas CN
J Asthma; 2015 Oct; 52(8):838-45. PubMed ID: 26037396
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers.
Nakate T; Yoshida H; Ohike A; Tokunaga Y; Ibuki R; Kawashima Y
Eur J Pharm Biopharm; 2003 Nov; 56(3):319-25. PubMed ID: 14602173
[TBL] [Abstract][Full Text] [Related]
11. Dry Powder Inhalers: From Bench to Bedside.
Chrystyn H; Azouz W; Tarsin W
J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):324-335. PubMed ID: 38016124
[TBL] [Abstract][Full Text] [Related]
12. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
Sommerfeld M; Cui Y; Schmalfuß S
Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
[TBL] [Abstract][Full Text] [Related]
13. Practical problems with aerosol therapy in COPD.
Rau JL
Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
[TBL] [Abstract][Full Text] [Related]
14. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
15. Design of dry powder inhalers to improve patient outcomes: it's not just about the device.
Weers JG
Expert Opin Drug Deliv; 2024 Mar; 21(3):365-380. PubMed ID: 38630860
[TBL] [Abstract][Full Text] [Related]
16. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
Lau M; Young PM; Traini D
Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Muralidharan P; Hayes D; Mansour HM
Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
[TBL] [Abstract][Full Text] [Related]
18. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
19. Devices for dry powder drug delivery to the lung.
Berkenfeld K; Lamprecht A; McConville JT
AAPS PharmSciTech; 2015 Jun; 16(3):479-90. PubMed ID: 25964142
[TBL] [Abstract][Full Text] [Related]
20. Technological and practical challenges of dry powder inhalers and formulations.
Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH
Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
